Ausgabe 11/2020
Inhalt (21 Artikel)
Immune resilience in response to cancer therapy
Joanina K. Gicobi, Whitney Barham, Haidong Dong
Augmenting engineered T-cell strategies in solid cancers through epigenetic priming
Aaraby Y. Nielsen, Maria Ormhøj, Sofie Traynor, Morten F. Gjerstorff
In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypes
Morten Nielsen, Anders Krarup-Hansen, Dorrit Hovgaard, Michael Mørk Petersen, Anand Chainsukh Loya, Marie Christine Wulff Westergaard, Inge Marie Svane, Niels Junker
Differences in the sensitivity of classically and alternatively activated macrophages to TAK1 inhibitor-induced necroptosis
Zsófia Varga, Tamás Molnár, Anett Mázló, Ramóna Kovács, Viktória Jenei, Krisztina Kerekes, Attila Bácsi, Gábor Koncz
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%
Alessio Cortellini, Marcello Tiseo, Giuseppe L. Banna, Federico Cappuzzo, Joachim G. J. V. Aerts, Fausto Barbieri, Raffaele Giusti, Emilio Bria, Diego Cortinovis, Francesco Grossi, Maria R. Migliorino, Domenico Galetta, Francesco Passiglia, Daniele Santini, Rossana Berardi, Alessandro Morabito, Carlo Genova, Francesca Mazzoni, Vincenzo Di Noia, Diego Signorelli, Alessandro Tuzi, Alain Gelibter, Paolo Marchetti, Marianna Macerelli, Francesca Rastelli, Rita Chiari, Danilo Rocco, Stefania Gori, Michele De Tursi, Giovanni Mansueto, Federica Zoratto, Matteo Santoni, Marianna Tudini, Erika Rijavec, Marco Filetti, Annamaria Catino, Pamela Pizzutilo, Luca Sala, Fabrizio Citarella, Russano Marco, Mariangela Torniai, Luca Cantini, Giada Targato, Vincenzo Sforza, Olga Nigro, Miriam G. Ferrara, Ettore D’Argento, Sebastiano Buti, Paola Bordi, Lorenzo Antonuzzo, Simona Scodes, Lorenza Landi, Giorgia Guaitoli, Cinzia Baldessari, Luigi Della Gravara, Maria Giovanna Dal Bello, Robert A. Belderbos, Paolo Bironzo, Simona Carnio, Serena Ricciardi, Alessio Grieco, Alessandro De Toma, Claudia Proto, Alex Friedlaender, Ornella Cantale, Biagio Ricciuti, Alfredo Addeo, Giulio Metro, Corrado Ficorella, Giampiero Porzio
Differences in PD-1 expression on CD8+ T-cells in chronic myeloid leukemia patients according to disease phase and TKI medication
Min Young Lee, Chan-Jeoung Park, Young-Uk Cho, Eunkyoung You, Seongsoo Jang, Chang Ahn Seol, Eul-Ju Seo, Eun-Ji Choi, Je-Hwan Lee
Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells
Mohammed L. Ibrahim, Chunwan Lu, John D. Klement, Priscilla S. Redd, Dafeng Yang, Alyssa D. Smith, Kebin Liu
Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients
H. Daiko, T. Marafioti, T. Fujiwara, Y. Shirakawa, T. Nakatsura, K. Kato, I. Puccio, T. Hikichi, S. Yoshimura, T. Nakagawa, M. Furukawa, K. Stoeber, M. Nagira, N. Ide, T. Kojima
Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8+ T cells
Charlotte M. Mousset, Willemijn Hobo, Aafke de Ligt, Sjoerd Baardman, Nicolaas P. M. Schaap, Joop H. Jansen, Anniek B. van der Waart, Harry Dolstra
Infiltration of T cells promotes the metastasis of ovarian cancer cells via the modulation of metastasis-related genes and PD-L1 expression
Jing-Jing Wang, Michelle Kwan-Yee Siu, Yu-Xin Jiang, David Wai Chan, Annie Nga-Yin Cheung, Hextan Yuen-Sheung Ngan, Karen Kar-Loen Chan
Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response
Sabrina Sapski, Nadine Beha, Roland E. Kontermann, Dafne Müller
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer
Qilai Long, Ai-Hong Ma, Hongyong Zhang, Zhixiu Cao, Roger Xia, Tzu-Yin Lin, Guru P. Sonpavde, Ralph de Vere White, Jianming Guo, Chong-Xian Pan
Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10
Elisabetta Michielon, Marta López González, Judith L. A. Burm, Taco Waaijman, Ekaterina S. Jordanova, Tanja D. de Gruijl, Susan Gibbs
CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment
Chao Xin, Jianmin Zhu, Song Gu, Minzhi Yin, Jing Ma, Ci Pan, Jingyan Tang, Peng Zhang, Yang Liu, Xue-Feng Bai, Xi Mo, Min Xu, Hua Zhu
ADRB3 expression in tumor cells is a poor prognostic factor and promotes proliferation in non-small cell lung carcinoma
Meng Zheng, Zhiling Zhou, Xiangting Tian, Dingzhang Xiao, Xinghua Hou, Zhi Xie, Haidan Liang, Shuguang Lin
Metabolomic profiling of tumor-infiltrating macrophages during tumor growth
Naoki Umemura, Masahiro Sugimoto, Yusuke Kitoh, Masanao Saio, Hiroshi Sakagami
IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma
Yujia Zheng, Yu Li, Bo Tang, Qitai Zhao, Dan Wang, Yulin Liu, Mengxing Guo, Song Zhao, Yu Qi, Yi Zhang, Lan Huang
Clinicopathological factors associated with tumor-infiltrating lymphocyte reactivity in breast cancer
Heejae Lee, Young-Ae Kim, Youngho Kim, Hye Seon Park, Jeong-Han Seo, Hyun Lee, Gyungyub Gong, Hee Jin Lee
Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors
Robin Fröbom, Erik Berglund, David Berglund, Inga-Lena Nilsson, Jan Åhlén, Karin von Sivers, Christina Linder-Stragliotto, Peter Suenaert, Alex Karlsson-Parra, Robert Bränström
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer
Mingjia Li, Daniel Spakowicz, Songzhu Zhao, Sandip H. Patel, Andrew Johns, Madison Grogan, Abdul Miah, Marium Husain, Kai He, Erin M. Bertino, Peter G. Shields, Lai Wei, David P. Carbone, Gregory A. Otterson, Carolyn J. Presley, Dwight H. Owen
Silent acute appendicitis revealed by PET-CT during treatment with ipilimumab and nivolumab: a new immune-related adverse event
C. Mangas, S. Leoni-Parvex, V. Spataro